Skip to main content
Caplight Logo









TJM

TJM

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://tjmtechnologies.com

Last Round

Series B

Jul 2, 2026

Est. Valuation

$375M

Total Funding Raised

$75M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TJM operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Series B round in July 2026.

TJM Labs is a healthcare technology company that provides an AI-powered platform to automate pharmacy operations, including prescription intake, data processing, and patient communication.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, NLP & Conversational AI, Workflow Automation, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TJM Comparables

Compare TJM with similar companies based on industry and business-model similarity.

TJM comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Asepha
72%
Innovaccer
70%
Sully.ai
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TJM Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 2, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

TJM Investors

Notable investors and investment history

TJM investors
InvestorRounds
Arthur VenturesSeries B
Updata PartnersSeries B
ElephantSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $75M round led by Elephant

Book a demo to see all signals

For institutional investors. Book with your work email.

TJM Filings

Explore SEC and related filing metadata, where available.

TJM filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TJM's valuation, stock price, and market status.

Is TJM a public or private company?

TJM is a private company.

What is the current stock price of TJM?

TJM is a private company, so its shares have no public market price. Caplight tracks TJM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TJM worth (valuation)?

TJM's valuation is estimated at $375.0M based on funding round data.

Can I buy TJM stock?

TJM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TJM's last funding round?

TJM's most recent funding round was Series B on July 2, 2026.

Who are the main investors in TJM?

Key investors in TJM include Elephant.

Will TJM IPO soon?

No public IPO plans have been announced for TJM.

How can I track TJM secondary market activity?

Caplight tracks bids, offers, and trades in TJM's shares on secondary markets.

Firmographic Details

HeadquartersWilmington, Delaware
Year Founded2024
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?